Related Experiment Video

Updated: Aug 17, 2026

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
14:48

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies

Published on: December 26, 2012

Vitamin E deficiency reduces surfactant lipid biosynthesis in alveolar type II cells

Florian Guthmann1, Ingrid Kolleck, Christian Schachtrup

  • 1Clinic of Neonatology, Humboldt-Universität zu Berlin, Charité Campus Mitte, Berlin, Germany

Free Radical Biology & Medicine
|March 14, 2003
PubMed

Insights

Vitamin E deficiency in rats reduced lung phospholipids, impacting phosphatidylcholine synthesis pathways in alveolar type II cells. This highlights vitamin E's crucial role in maintaining lung surfactant health.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Cell Biology

Background:

  • Reactive oxygen species contribute to lung injury.
  • Neonates are susceptible to lung disorders linked to surfactant deficiency and low vitamin E.
  • Vitamin E status may influence lung phospholipid content.

Purpose of the Study:

  • To investigate the effect of vitamin E status on phospholipids in rat bronchoalveolar lavage and type II cells.
  • To determine how vitamin E affects phosphatidylcholine synthesis via de novo and reacylation pathways.

Main Methods:

  • Assessed phospholipid content in bronchoalveolar lavage and type II cells.
  • Measured glycerol-3-phosphate O-acyltransferase (G3P-AT) activity.
  • Investigated de novo synthesis and lyso-phosphatidylcholine reacylation in type II cells.
  • Utilized dithiothreitol and chelerythrine to probe enzyme activity and signaling pathways.

Main Results:

  • Vitamin E depletion decreased phospholipids in bronchoalveolar lavage and type II cells.
  • G3P-AT activity, de novo synthesis, and reacylation of phosphatidylcholine were reduced by vitamin E depletion.
  • Dithiothreitol restored G3P-AT activity and de novo synthesis but inhibited reacylation.
  • Protein kinase C inhibition significantly reduced reacylation.

Conclusions:

  • Vitamin E regulates phosphatidylcholine synthesis through both de novo and reacylation pathways in alveolar type II cells.
  • The antioxidant and protein kinase C-modulating properties of vitamin E are key to these regulatory functions.
  • Vitamin E depletion impairs phospholipid synthesis, leading to reduced alveolar surfactant content in rats.

More Related Videos

Generating 3D Spheres and 2D Air-Liquid Interface Cultures of Human Induced Pluripotent Stem Cell-Derived Type 2 Alveolar Epithelial Cells07:02

Generating 3D Spheres and 2D Air-Liquid Interface Cultures of Human Induced Pluripotent Stem Cell-Derived Type 2 Alveolar Epithelial Cells

Published on: April 15, 2022

Isolation of Lung Retinoid-Containing Cells by Cell Sorting07:47

Isolation of Lung Retinoid-Containing Cells by Cell Sorting

Published on: April 11, 2025

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.